Bedside Assessment of Autonomic Dysfunction in Multiple System Atrophy

J Parkinsons Dis. 2022;12(7):2277-2281. doi: 10.3233/JPD-223357.

Abstract

Multiple system atrophy (MSA) is a rare, rapidly progressive neurodegenerative disorder of the adulthood, characterized by autonomic failure, parkinsonian and cerebellar features in various combinations. Distinguishing MSA from common clinical look-alikes such as Parkinson's disease, other atypical parkinsonian disorders or alternative causes of sporadic adult-onset cerebellar ataxia may be difficult, especially at early disease stages. Nonetheless, some simple and cost-effective screening tools help detecting important red flags guiding towards a MSA diagnosis. Here we outline which clinical pearls and bedside tests may disclose autonomic dysfunction in multiple domains, enabling an early MSA diagnosis and, even more importantly, personalized treatment.

Keywords: Dysautonomia; multiple system atrophy; neurogenic bladder; orthostatic hypotension; parkinsonian disorders; vasomotor control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Autonomic Nervous System Diseases* / diagnosis
  • Autonomic Nervous System Diseases* / etiology
  • Cerebellum
  • Humans
  • Multiple System Atrophy* / complications
  • Multiple System Atrophy* / diagnosis
  • Parkinson Disease* / complications
  • Parkinson Disease* / diagnosis
  • Parkinsonian Disorders* / diagnosis